Acute myocarditis following administration of BNT162b2 vaccine
<p dir="ltr">The wide use of vaccines was linked with rare but serious complications in adults, causing a global concern. Here, we describe a young male patient, who presented with acute myocarditis, three days after the second dose of BNT162b2 vaccine.</p><h2>Other Infor...
Saved in:
| Main Author: | Mhd Baraa Habib (11721774) (author) |
|---|---|
| Other Authors: | Tahseen Hamamyh (16810761) (author), Ahmed Elyas (17280673) (author), Mohammed Altermanini (17280676) (author), Mawahib Elhassan (14777326) (author) |
| Published: |
2021
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical outcomes of Pfizer‐BioNTech COVID‐19 vaccine in children and adolescents: A systematic review
by: Ahmad R. Al‐Qudimat (21348626)
Published: (2022) -
Syncope following Pfizer BioNTech (bnt162b2) vaccination unmasking Brugada syndrome
by: Mohammad Altermanini (16810755)
Published: (2023) -
Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study
by: Farah M. Shurrab (16324961)
Published: (2022) -
The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout
by: Ahmed Zaqout (9538566)
Published: (2021) -
Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
by: Zohaib Yousaf (9617058)
Published: (2022)